Nanomik, founded in 2013 in Turkey, is an innovative biotechnology startup leading change in the life sciences industry with its slogan "Biochemistry leading change in life sciences." The company specializes in developing and producing microencapsulated biopesticides for food and agricultural products, offering protection against food spoilage without altering their quality. By addressing the global issue of food waste, Nanomik aims to minimize losses, which currently account for approximately 30% of fresh fruits and vegetables before reaching consumers, resulting in a staggering economic impact of over $1.3 billion annually. The conventional methods of preserving food rely on harmful chemicals and synthetic derivatives, posing risks to both human health and the environment. Nanomik has garnered significant support, receiving a substantial €800.00K grant investment on 21 December 2022 from a diverse group of investors including CVentures, Arya Women's Investment Platform, Rockstart Accelerator, TRANGELS, Yasemin Mistikoglu, Ozlem Tumer Eke, Münteha Adalı, ITU ARI Teknokent. The company's vision revolves around demonstrating that natural methods can effectively protect food and agricultural products, reducing the dependency on harmful chemicals and minimizing food waste. With a focus on biotechnology, life sciences, and AgriTech, Nanomik's mission aligns with the global shift towards natural products and healthy foods. Through its innovative solutions, the company aims to positively impact the industry while mitigating the adverse effects of traditional preservation methods. Nanomik's commitment to sustainability and its innovative approach position it as a promising player in the rapidly evolving agri-biotech sector.
Funding Stage | Amount | No. Investors | Investors | Date |
---|---|---|---|---|
Grant | €800.00K | 8 | Yasemin Mistikoglu, Ozlem Tumer Eke +2 | 21 Dec 2022 |
Seed Round | €800.00K | 1 | 05 Dec 2022 | |
Non Equity Assistance | Unknown | 1 | 19 Apr 2022 | |
Seed Round | €100.00K | 1 | 09 Sep 2020 | |
Convertible Note | €100.00K | 1 | 05 Jul 2020 |
No recent news or press coverage available for Nanomik Biotechnology.